Atomoxetine Improved Attention in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Dyslexia in a 16 Week, Acute, Randomized, Double-Blind Trial

David Williams, Bennett Shaywitz, Stephen R. Hooper, Sally Shaywitz, Linda Wietecha, Sharon B. Wigal, David Dunn, Keith McBurnett
The purpose of this study was to evaluate atomoxetine treatment effects in attention-deficit/hyperactivity disorder (ADHD-only), attention-deficit/hyperactivity disorder with comorbid dyslexia (ADHD+D), or dyslexia only on ADHD core symptoms and on sluggish cognitive tempo (SCT), working memory, life performance, and self-concept.
doi:10.17615/y6hm-9t10 fatcat:6hi7o3bugvffdbnph35zjre2ne